Results 71 to 80 of about 4,246 (205)
Clinical Case Reports, Volume 13, Issue 10, October 2025.Post‐operative Axial Non‐enhanced brain CT scan of an 83‐year‐old male with chronic subdural hematoma, which was evacuated with burrhole craniotomy. The image shows a subarachnoid hemorrhage at the posterior fossa (left image), bilateral convexity (middle image). The basal cisterns are open despite the hemorrhage.
Sadegh Bagherzadeh +3 more
wiley +1 more source
Stroke: Vascular and Interventional Neurology, 2023 Introduction There is increasing literature to support the efficacy of middle meningeal artery (MMA) embolization in the treatment of chronic subdural hematomas (cSDH). Techniques for optimal embolization of the MMA are yet to be elucidated.
Benjamen M. Meyer +12 more
openaire +3 more sources
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Frontiers in Neurology, 2020 Chronic subdural hematoma (cSDH) is a common disease process associated with significant morbidity that occurs most often in elderly patients. Asymptomatic patients are typically treated conservatively, with surgical intervention reserved for patients ...
Joshua S. Catapano +4 more
doaj +1 more source
Clinical Case Reports, Volume 13, Issue 9, September 2025.ABSTRACT This case highlights that calcified chronic subdural hematoma (CCSDH) may induce adjacent cranial thickening due to chronic cerebral hypoperfusion and metabolic disturbances. Surgical resection can be performed safely, but psychiatric symptoms (e.g., depression, insomnia) may persist postoperatively, suggesting they are not always hematoma ...
Xiaoyong Yang +3 more
wiley +1 more source
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase [PDF]
Scientific Reports, 2019 AbstractThe Dex-CSDH trial is a randomised, double-blind, placebo-controlled trial of dexamethasone for patients with a symptomatic chronic subdural haematoma. The trial commenced with an internal pilot, whose primary objective was to assess the feasibility of multi-centre recruitment.
Ellie Edlmann +66 more
openaire +5 more sources
Management of chronic subdural hematoma in spontaneous intracranial hypotension
Brain and SpineIntroduction: There is no accepted algorithm for the management of chronic subdural hematoma (cSDH) caused by spinal CSF leaks in spontaneous intracranial hypotension (SIH).
Manou Overstijns +9 more
doaj +1 more source
Financial Literacy and Healthcare Access Among US Adults Before and During COVID‐19
FINANCIAL PLANNING REVIEW, Volume 8, Issue 3, September 2025.ABSTRACT This paper explores the role of financial literacy in US healthcare access before and during the COVID‐19 pandemic. We use survey data from the 2018 and 2021 National Financial Capability Study (NFCS) waves. We estimate weighted logistic regression models for the combined 2018 and 2021 samples separately, using two measures of financial ...
Abdullah Noman, Redwan Bin Abdul Baten
wiley +1 more source
Rethinking ethnic migrant health research: creating space for diverse paradigms
Kōtuitui: New Zealand Journal of Social Sciences Online, Volume 20, Issue 3, Page 279-301, September 2025.ABSTRACT Health research often does not reflect the diversity of worldviews and knowingness inherent in Aotearoa New Zealand (NZ). Eurocentric paradigms – grounded in individualism, empirical rationalism, objectivity, neutrality, and the universality of theories – continue to dominate.
Rachel Mukwezwa Tapera
wiley +1 more source
Single Burr Hole and Drainage in Chronic Subdural Hematoma: Outcome in Consecutive 333 Cases
Nepal Journal of Neuroscience, 2016 Chronic subdural hematoma (CSDH) is a common neurosurgical disease with incidence 3 in 100,000 in general population. Recorded or trivial head injury is the most common cause of CSDH with several predisposing factors like alcoholism, coagulopathy ...
Yam B Roka +3 more
doaj +1 more source
A review of frequently used Kampo prescriptions; Part 6—Goreisan
Traditional &Kampo Medicine, Volume 12, Issue 2, Page 121-134, August 2025.Abstract Background Goreisan (GRS), first described in Shang Han Lun and Jin Gui Yao Lue during the Han dynasty, is indicated for thirst and oliguria. Key Findings The use of Goreisan (GRS) to treat headaches has increased in Japan. The Kampo physicians Keisetsu Otsuka and Doumei Yakazu applied GRS for trigeminal neuralgia or headache, and Hajime ...
Yoshihide Yakazu +6 more
wiley +1 more source